Annex 1 – Are You Ready For Implementation Of The New Annex?

The recent revision of the EU Annex 1 has introduced significant changes that are poised to reshape pharmaceutical manufacturing standards. Dive into insightful discussions with PharmaLex expert Patrick Nieuwenhuizen as he illuminates the key revisions and offers strategic insights on effectively implementing the updated Annex 1 guidelines within the industry.

Explore the implications of these changes and gain invaluable guidance on navigating the evolving regulatory landscape for pharmaceutical manufacturing by listening to the podcast episode below.